More Questions on this Topic
More Questions on this Topic ( 35 Questions)
A nurse is caring for a client who is receiving magnesium sulfate for severe preeclampsia.
Which of the following actions should the nurse take?
Administer calcium gluconate as an antidote if toxicity occurs. Magnesium sulfate is a mineral that reduces seizure risks in women with severe preeclampsia. However, it can also cause side effects and toxicity, such as respiratory depression, muscle weakness, and cardiac arrest. Calcium gluconate is an antidote that can reverse the effects of magnesium sulfate and restore normal neuromuscular function.
Magnesium sulfate does not affect blood glucose levels.
There is no need to monitor the client’s blood glucose level every 4 hours.
The infusion should be discontinued if the client’s respiratory rate is below 12/min, not 16/min.
A low respiratory rate indicates respiratory depression, which is a sign of magnesium toxicity.
The infusion rate should not be increased if the client’s urine output is above 30 mL/hr. Urine output should be at least 30 mL/hr while administering magnesium sulfate to prevent accumulation of the drug in the body.
Increasing the infusion rate can increase the risk of toxicity.
Administer calcium gluconate as an antidote if toxicity occurs. Magnesium sulfate is a mineral that reduces seizure risks in women with severe preeclampsia. However, it can also cause side effects and toxicity, such as respiratory depression, muscle weakness, and cardiac arrest. Calcium gluconate is an antidote that can reverse the effects of magnesium sulfate and restore normal neuromuscular function.
Choice B is wrong because magnesium sulfate does not affect blood glucose levels.
There is no need to monitor the client’s blood glucose level every 4 hours.
Choice C is wrong because the infusion should be discontinued if the client’s respiratory rate is below 12/min, not 16/min.
A low respiratory rate indicates respiratory depression, which is a sign of magnesium toxicity.
Choice D is wrong because the infusion rate should not be increased if the client’s urine output is above 30 mL/hr. Urine output should be at least 30 mL/hr while administering magnesium sulfate to prevent accumulation of the drug in the body.
Increasing the infusion rate can increase the risk of toxicity.